1. Cell Host Microbe. 2018 Jun 13;23(6):702-704. doi: 10.1016/j.chom.2018.05.016.

Cutting-Edge Infectious Disease Diagnostics with CRISPR.

Chiu C(1).

Author information:
(1)Department of Laboratory Medicine and Medicine, Division of Infectious 
Diseases, University of California, San Francisco, San Francisco, CA 94107, USA; 
UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA 91407, 
USA. Electronic address: charles.chiu@ucsf.edu.

Comment on
    Science. 2018 Apr 27;360(6387):439-444. doi: 10.1126/science.aaq0179.
    Science. 2018 Apr 27;360(6387):436-439. doi: 10.1126/science.aar6245.
    Science. 2018 Apr 27;360(6387):444-448. doi: 10.1126/science.aas8836.

Three recent Science articles (Chen et al., 2018; Gootenberg et al., 2018; 
Myhrvold et al., 2018) describe the use of CRISPR-Cas technology to develop 
point-of-care diagnostics that directly detect viruses from clinical samples. 
These tests could radically transform approaches to diagnosing infectious 
diseases at the bedside and in the field.

Copyright © 2018 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.chom.2018.05.016
PMCID: PMC7105017
PMID: 29902435 [Indexed for MEDLINE]